Logo - springer
Slogan - springer

Materials - Biomaterials | Regenerative Engineering and Translational Medicine

We’re working on a new version of this journal site - preview it now
Regenerative Engineering and Translational Medicine

Regenerative Engineering and Translational Medicine

Editor-in-Chief: Cato T. Laurencin

ISSN: 2364-4133 (print version)
ISSN: 2364-4141 (electronic version)

Journal no. 40883

Ethics & Disclosures

The journal is committed to maintaining the highest level of integrity in the content published.
This journal has a Conflict of Interest policy in place and complies with international, national and institutional standards on research involving Human Participants and Animals and Informed Consent.
CI_Logo_COPE_single_95px
The journal is a member of the Committee on Publication Ethics (COPE) and subscribes to its principles on how to deal with acts of misconduct thereby committing to investigate allegations of misconduct in order to ensure the integrity of research.
Content published in this journal is peer reviewed.

Read this Journal on Springerlink

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Regenerative Engineering is an international journal covering convergence of the disciplines of tissue engineering, advanced materials science, stem cell research, the physical sciences, and areas of developmental biology. This convergence brings exciting opportunities to translate bench-top research into bedside methods, allowing the possibility of moving beyond maintaining or repairing tissues to regenerating them. The journal encourages both top-down engineering approaches and bottom-up strategies integrating materials science with stem cell research and developmental biology. Convergence papers on instructive biomaterials, stimuli-responsive biomaterials, micro- and nano-patterning for regenerative engineering, elastomeric biomaterials, hydrogels for tissue engineering, and rapid prototyping and bioprinting approaches are particularly welcome.

    The journal provides a premier, single-blind peer-reviewed forum for the publication of original papers, authoritative reviews, rapid communications, news and views, and opinion papers addressing the most important issues and efforts toward successfully regenerating complex human tissues and organs. All research articles feature a lay abstract highlighting the relevance and future impact for patients, government and other health officials, and members of the general public. Bridging the gap between the lab and the clinic, the journal also serves as a dedicated platform for showcasing translational research that brings basic scientific research and discoveries into clinical methods and therapies, contributing to the improvement of human health care.

    Topics covered in Regenerative Engineering and Translational Medicine include:

    • Advanced materials science for regenerative and biomedical applications
    • Stem cells for tissue regeneration
    • Drug delivery for tissue regeneration
    • Nanomaterials and nanobiotechnology for tissue regeneration
    • Studies combining tissue engineering/regeneration with developmental biology
    • Convergence research in pre-clinical and clinical phases
  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors (docx, 129 kB)
  • Ethics & Disclosures

    Ethics & Disclosures

    Close

Alerts for this journal

 

Get the table of contents of every new issue published in Regenerative Engineering and Translational Medicine.